New daily weight-loss pill shows success at clinical trial
Move over, Med diet – plantains and cassava can be as healthy as tomatoes and olive oil, say researchers
In the red: global wine sales fall to lowest levels since 1961
China accuses UK politicians of ‘arrogance’ in British Steel row
New daily weight-loss pill shows success at clinical trial
Move over, Med diet – plantains and cassava can be as healthy as tomatoes and olive oil, say researchers
In the red: global wine sales fall to lowest levels since 1961
China accuses UK politicians of ‘arrogance’ in British Steel row
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia
Britain’s drugs regulator has approved a groundbreaking treatment for two painful and debilitating lifelong blood disorders, which works by “editing” the gene that causes them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for Casgevy to be used to treat sickle cell disease and beta thalassemia.
Notifications
More Stories
Revealed: Chinese researchers can access half a million UK GP records
About 15% of world’s cropland polluted with toxic metals, say researchers
Rebecca Hendin on life outside our solar system – cartoon